AR090842A1 - Cuantificacion de impurezas para ensayos de liberacion de productos peptidicos - Google Patents

Cuantificacion de impurezas para ensayos de liberacion de productos peptidicos

Info

Publication number
AR090842A1
AR090842A1 ARP130101390A ARP130101390A AR090842A1 AR 090842 A1 AR090842 A1 AR 090842A1 AR P130101390 A ARP130101390 A AR P130101390A AR P130101390 A ARP130101390 A AR P130101390A AR 090842 A1 AR090842 A1 AR 090842A1
Authority
AR
Argentina
Prior art keywords
impurities
quantification
product release
release tests
peptidic product
Prior art date
Application number
ARP130101390A
Other languages
English (en)
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of AR090842A1 publication Critical patent/AR090842A1/es

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848Methods of protein analysis involving mass spectrometry

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Método para la determinación cuantitativa de una impureza presente en un producto peptídico, donde la impureza no se puede separar de otras impurezas del producto principal. El método implica particularmente el uso de la detección por espectrometría de masas de alta resolución (EM) con o sin cromatografía líquida de alta resolución (HPLC). El método se puede utilizar para la investigación de la calidad de péptidos y proteínas, particularmente de péptidos y proteínas farmacéuticas. Kit.
ARP130101390A 2012-04-27 2013-04-25 Cuantificacion de impurezas para ensayos de liberacion de productos peptidicos AR090842A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2012/057771 WO2013182217A1 (en) 2012-04-27 2012-04-27 Quantification of impurities for release testing of peptide products

Publications (1)

Publication Number Publication Date
AR090842A1 true AR090842A1 (es) 2014-12-10

Family

ID=48227257

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP130101390A AR090842A1 (es) 2012-04-27 2013-04-25 Cuantificacion de impurezas para ensayos de liberacion de productos peptidicos

Country Status (16)

Country Link
JP (1) JP6121522B2 (es)
KR (1) KR102071737B1 (es)
CN (1) CN104246508B (es)
AR (1) AR090842A1 (es)
AU (1) AU2013254728B2 (es)
BR (1) BR112014026613B1 (es)
CA (1) CA2869041C (es)
DK (1) DK2841950T3 (es)
EA (1) EA029893B1 (es)
ES (1) ES2702712T3 (es)
HU (1) HUE042296T2 (es)
IL (1) IL234914A (es)
MX (1) MX353306B (es)
SG (1) SG11201406094XA (es)
TW (1) TWI589874B (es)
WO (2) WO2013182217A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA116217C2 (uk) 2012-10-09 2018-02-26 Санофі Пептидна сполука як подвійний агоніст рецепторів glp1-1 та глюкагону
AR094180A1 (es) 2012-12-21 2015-07-15 Sanofi Sa Derivados de exendina-4
EP3080152A1 (en) 2013-12-13 2016-10-19 Sanofi Non-acylated exendin-4 peptide analogues
EP3080149A1 (en) 2013-12-13 2016-10-19 Sanofi Dual glp-1/glucagon receptor agonists
EP3080150B1 (en) 2013-12-13 2018-08-01 Sanofi Exendin-4 peptide analogues as dual glp-1/gip receptor agonists
WO2015086729A1 (en) 2013-12-13 2015-06-18 Sanofi Dual glp-1/gip receptor agonists
TW201625669A (zh) 2014-04-07 2016-07-16 賽諾菲公司 衍生自艾塞那肽-4(Exendin-4)之肽類雙重GLP-1/升糖素受體促效劑
TW201625668A (zh) 2014-04-07 2016-07-16 賽諾菲公司 作為胜肽性雙重glp-1/昇糖素受體激動劑之艾塞那肽-4衍生物
TW201625670A (zh) 2014-04-07 2016-07-16 賽諾菲公司 衍生自exendin-4之雙重glp-1/升糖素受體促效劑
US9932381B2 (en) 2014-06-18 2018-04-03 Sanofi Exendin-4 derivatives as selective glucagon receptor agonists
CN104211801A (zh) * 2014-07-25 2014-12-17 杭州诺泰制药技术有限公司 一种制备利西拉来的方法
CN106153748B (zh) * 2015-03-31 2019-02-22 深圳翰宇药业股份有限公司 一种检测多肽中n,n-二异丙基碳二亚胺的方法
AR105319A1 (es) 2015-06-05 2017-09-27 Sanofi Sa Profármacos que comprenden un conjugado agonista dual de glp-1 / glucagón conector ácido hialurónico
AR105284A1 (es) 2015-07-10 2017-09-20 Sanofi Sa Derivados de exendina-4 como agonistas peptídicos duales específicos de los receptores de glp-1 / glucagón
JP6505268B1 (ja) * 2018-01-11 2019-04-24 株式会社日立ハイテクサイエンス 質量分析装置及び質量分析方法
TW202045927A (zh) * 2019-02-27 2020-12-16 法商賽諾菲公司 以具內標之lc-ms於樣品中進行聚山梨醇酯定量之方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ512663A (en) * 1999-01-14 2004-05-28 Amylin Pharmaceuticals Inc Novel exendin agonist formulations and methods of administration thereof
US6451611B1 (en) * 2000-07-28 2002-09-17 Statens Serum Institute Quantitative analysis of hexose-monophosphates from biological samples
US7427675B2 (en) * 2004-08-23 2008-09-23 Isis Pharmaceuticals, Inc. Compounds and methods for the characterization of oligonucleotides
DE102004043153B4 (de) * 2004-09-03 2013-11-21 Philipps-Universität Marburg Erfindung betreffend GLP-1 und Exendin
US20130137645A1 (en) * 2010-07-19 2013-05-30 Mary S. Rosendahl Modified peptides and proteins

Also Published As

Publication number Publication date
BR112014026613B1 (pt) 2021-12-21
SG11201406094XA (en) 2014-10-30
TWI589874B (zh) 2017-07-01
MX353306B (es) 2018-01-08
TW201348701A (zh) 2013-12-01
CA2869041C (en) 2021-05-04
KR102071737B1 (ko) 2020-01-30
EA029893B1 (ru) 2018-05-31
ES2702712T3 (es) 2019-03-05
WO2013182217A1 (en) 2013-12-12
WO2013160397A1 (en) 2013-10-31
HUE042296T2 (hu) 2019-06-28
DK2841950T3 (en) 2019-01-14
AU2013254728A1 (en) 2014-11-20
JP2015515004A (ja) 2015-05-21
AU2013254728B2 (en) 2018-04-12
CA2869041A1 (en) 2013-10-31
MX2014012826A (es) 2015-11-13
JP6121522B2 (ja) 2017-04-26
CN104246508A (zh) 2014-12-24
BR112014026613A2 (pt) 2017-07-18
KR20150003794A (ko) 2015-01-09
EA201491974A1 (ru) 2015-02-27
IL234914A (en) 2017-12-31
CN104246508B (zh) 2016-06-08

Similar Documents

Publication Publication Date Title
AR090842A1 (es) Cuantificacion de impurezas para ensayos de liberacion de productos peptidicos
BR112017018821A2 (pt) métodos para quantificação de níveis de insulina através de espectrometria de massa
CO7200249A2 (es) Variantes de oxintomodulina de acción prolongada y métodos de producción de las mismas
PH12015502849A1 (en) Biomarkers for cognitive dysfunction diseases and method for detecting cognitive dysfunction disease using biomarkers
WO2016004233A3 (en) Srm assays to chemotherapy targets
WO2015157704A3 (en) Methods and compositions for detecting misfolded proteins
BR112017017854A2 (pt) método para detecção de anticorpo monoclonal utilizando espectrometria de massa
WO2015095355A3 (en) Detection of an antibody against a pathogen
WO2014146139A3 (en) Srm assay to indicate cancer therapy
WO2018072862A8 (de) Verfahren zum auswerten von daten einer massenspektrometrie und massenspektrometrisches verfahren sowie ein maldi tof massenspektrometer
BR112015005887A2 (pt) quantificação de tiroglobulina por espectroscopia de massa
MX2017000083A (es) Compuestos de platino, composiciones y usos de estos.
WO2014207049A3 (de) Verfahren zur bestimmung von proteinaggregaten unter verwendung von oberflächen-fida
BR112017017975A2 (pt) kit para preparação de amostra para detecção de anticorpo monoclonal
WO2014195917A3 (en) Detector-array-based sample characterization
ES2684758T3 (es) Procedimiento para diagnosticar fibrosis hepática
WO2016209773A9 (en) Improved assays and methods for allergen detection
CL2017000200A1 (es) Célula huésped mejorada para producir proteinas
BR112016000231A8 (pt) métodos para identificações de condições de separação com cromatografia de troca de íons e para análises de composições de polipeptídeos
WO2013184995A8 (en) Methods and apparatus for performing mass spectrometry
MX2016006457A (es) Analisis de cromatografia liquida de alto rendimiento (hplc) de impurezas en dianhidrogalactitol.
WO2018029350A3 (en) Methods of making and using soluble mhc molecules
CL2022000352A1 (es) Método para la caracterización de polipéptidos que se unen a complejos de péptido:mhc
ES2610081T3 (es) Estimación in vitro de eventos cardiovasculares mediante el ensayo para neo epitopos de la proteína Titin
SG11201907866SA (en) Horseshoe crab factor b variant

Legal Events

Date Code Title Description
FB Suspension of granting procedure